文献速递其他结缔组织病

半定量评分疾病顶端范围可预测系统性硬化症合并早期间质性肺病患者的肺总量变化

Semi-quantitatively scored apical extent of disease predicts change in total lung capacity in patients with systemic sclerosis and early interstitial lung disease.
PubMed 文献 · Semin Arthritis Rheum · 2025-01-31

研究纳入185例系统性硬化症患者,对基线和1年随访的胸部HRCT进行半定量视觉评分(网格影、磨玻璃影、肺气肿、病变范围,分5个水平从肺尖至肺底),分析其与肺功能参数变化的关系。结果发现肺尖(水平1)病变范围和水平3网格影与TLC变化相关,提示中上肺野病变可能具有临床意义。

要点

  • 肺尖(水平1)病变范围可预测TLC变化(校正R²=0.024,P=0.021)。
  • 排除肺气肿或肺动脉高压患者后,水平3网格影预测TLC变化(校正R²=0.026,P=0.020)。
  • 所有HRCT变量与肺功能参数横断面相关。

核心结论

  • 在系统性硬化症合并肺部受累的患者中,中上肺野的病变范围和网格影可预测TLC变化,可能具有临床重要性。

研究设计与样本

  • 来自针对性医疗项目的系统性硬化症患者,纳入标准为具备基线和1年随访的肺功能检查及同期胸部HRCT视觉评分,共185例(女性85%,首次症状平均年龄40岁)。
  • 对肺实质进行半定量视觉评分(网格影、磨玻璃影、肺气肿和病变范围),分5个水平从肺尖至肺底,采用线性检查并排除多重共线性后的回归分析预测肺功能参数变化。

主要发现

  • 所有HRCT变量与肺功能参数横断面相关。
  • 肺尖(水平1)病变范围和网格影、水平2网格影、水平3病变范围和网格影均与TLC显著相关(r 0.151-0.17,P<0.05)。
  • 肺尖(水平1)病变范围预测TLC变化(校正R²=0.024,P=0.021)。
  • 排除肺气肿或肺动脉高压患者后,水平3网格影预测TLC变化(校正R²=0.026,P=0.020)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pulmonary function tests (PFTs) and extent of ILD on HRCT predict mortality in systemic sclerosis associated interstitial lung disease (SSc-ILD). It is not known whether location and type in addition to extent of affected lung parenchyma are associated with PFTs changes. METHODS: SSc patients from a targeted healthcare program were included when PFTs and visually scored concomitant chest HRCT and PFTs at one year follow-up were available. Lung parenchyma of SSc patients was semi-quantitatively scored by visual assessment (reticulation, ground glass opacities, emphysema and disease extent) at five levels from apex to base. Regression analysis after linearity check and excluding multicollinearity was used to predict changes in PFT parameters (TLC, total lung capacity; FVC, forced vital capacity; DLCO, diffusion capacity for carbon monoxide). RESULTS: A total of 185 patients were included (85% female, mean age at first symptoms 40 years). All HRCT variables correlated with PFT parameters cross-sectionally. Disease extent and reticulation at the apices (level 1), reticulation at level 2, disease extent and reticulation at level 3 all correlated significantly with TLC (r 0.151-0.17, p < 0.05). Of these HRCT variables disease extent at level 1 predicted change in TLC (adjusted R2 0.024, p 0.021) and when excluding patients with emphysema or pulmonary hypertension, reticulation at level 3 predicted change in TLC (adjusted R2 0.026, p 0.020). CONCLUSIONS: In patients with systemic sclerosis and lung involvement, disease extent and reticulation at the mid-upper zones predicted change in TLC which may be of clinical importance.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. van Doorn-Hogervorst KMC, Marges ERE, Schouffoer AAA, et al. Semi-quantitatively scored apical extent of disease predicts change in total lung capacity in patients with systemic sclerosis and early interstitial lung disease. Semin Arthritis Rheum. 2025. PMID: 39914260. doi:10.1016/j.semarthrit.2025.152650

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。